| Ticker: | VRCA |
| Current Price: | $3.56 |
| % Daily Change: | -4.30% |
| Volume (1,000s): | 18.67 |
| Average Volume (1,000s): | 54.68 |
| Market Cap (M): | $61.16 |
| 1/2/2024 Price: | $8.40 |
| Change Since Inception: | -57.62% |
Verrica Pharmaceuticals Inc.
44 West Gay Street
Suite 400
West Chester, PA 19380
United States
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. We believe there’s a better way to safely and effectively bring relief to patients, deliver peace of mind to parents and caregivers, and advance accessible therapies to prescribers and payers. We are focused on changing the narrative around skin diseases and making treatment a more efficient process for both physicians and patients.
Headquartered in West Chester, Pennsylvania, Verrica was founded in 2013. We are led by a seasoned management team with extensive pharmaceutical industry experience ranging from drug development through commercialization and collectively launched more than 50 products.